
Time 2 Decide
Case Based Approaches To Optimal A1C Reduction In Type 2 Diabetes
Time 2 Decide is a case-based, modular program that reviews the goals of therapy for people with type 2 diabetes (T2D) and the limitations of current therapies. It showcases a new option for management of T2D, GLP-1/GIP dual receptor agonist therapy and explores where this new therapy fits into the treatment landscape. The program includes interactive decision points where participants decide which therapy(ies) would be best and engage in discussions of pros and cons of potential strategies, supported by guidelines and clinical trial data.
This program uses a passcode-based access system. Different resources are available with different passcodes. Common resources are available without a passcode.
Important Note
NOTE: This program requires a program-specific passcode and is NOT accessed using your CPD Network username.
Access Additional Resources
Enter your passcode to unlock specialized resources